p. 1−10
2717-1396
Vol.3/No.4
p. 11−18
2717-1396
Vol.3/No.4
p. 19−32
2717-1396
Vol.3/No.4
p. 33−42
2717-1396
Vol.3/No.4
p. 43−46
2717-1396
Vol.3/No.4
p. 47−54
2717-1396
Vol.3/No.4
0.05). According t resultos, we can be concluded that new designed nanoemulsion (500 ML) had not serious side effects on mice, and then this nanoemulsion might act as a drug carrier especially anticancer drugs.]]>
p. 55−62
2717-1396
Vol.3/No.4
p. 63−72
2717-1396
Vol.3/No.4
p. 73−78
2717-1396
Vol.3/No.4